正在加载视频...
视频加载失败
Chinese scientists have developed the world’s first iPSC-derived allogeneic cell therapy for drug-resistant epilepsy to win both China NMPA and US FDA clinical trial approvals. Unlike conventional drugs that mainly suppress symptoms, this therapy directly targets the damaged neurons at the root of seizures, repairs neural circuits, and aims... show more
12,921 次观看 • 4 个月前 •via X (Twitter)
0 条评论
暂无评论
原始帖子的评论将显示在这里
